BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 8628889)

  • 1. Contrast-enhanced MR imaging assessment of tumor capillary permeability: effect of irradiation on delivery of chemotherapy.
    Schwickert HC; Stiskal M; Roberts TP; van Dijke CF; Mann J; Mühler A; Shames DM; Demsar F; Disston A; Brasch RC
    Radiology; 1996 Mar; 198(3):893-8. PubMed ID: 8628889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mammary carcinoma model: correlation of macromolecular contrast-enhanced MR imaging characterizations of tumor microvasculature and histologic capillary density.
    van Dijke CF; Brasch RC; Roberts TP; Weidner N; Mathur A; Shames DM; Mann JS; Demsar F; Lang P; Schwickert HC
    Radiology; 1996 Mar; 198(3):813-8. PubMed ID: 8628876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrast-enhanced magnetic resonance imaging estimation of altered capillary permeability in experimental mammary carcinomas after X-irradiation.
    Cohen FM; Kuwatsuru R; Shames DM; Neuder M; Mann JS; Vexler V; Rosenau W; Brasch RC
    Invest Radiol; 1994 Nov; 29(11):970-7. PubMed ID: 7890512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time and dose dependency of radiation-induced changes in tumor microvascular characteristics using contrast-enhanced magnetic resonance imaging: impact on the delivery of chemotherapeutic agents.
    Schmidt HC; Brasch RC; Roberts TP; Shames DM; van Dijke CF; Stiskal M; Mann JS; Mühler A; Demsar F
    Acad Radiol; 1996 Aug; 3 Suppl 2():S347-8. PubMed ID: 8796600
    [No Abstract]   [Full Text] [Related]  

  • 5. Quantification of capillary permeability to macromolecular magnetic resonance imaging contrast media in experimental mammary adenocarcinomas.
    Brasch RC; Shames DM; Cohen FM; Kuwatsuru R; Neuder M; Mann JS; Vexler V; Mühler A; Rosenau W
    Invest Radiol; 1994 Jun; 29 Suppl 2():S8-11. PubMed ID: 7928277
    [No Abstract]   [Full Text] [Related]  

  • 6. Correlation of dynamic contrast-enhanced MR imaging with histologic tumor grade: comparison of macromolecular and small-molecular contrast media.
    Daldrup H; Shames DM; Wendland M; Okuhata Y; Link TM; Rosenau W; Lu Y; Brasch RC
    AJR Am J Roentgenol; 1998 Oct; 171(4):941-9. PubMed ID: 9762973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arthritic temporomandibular joint: correlation of macromolecular contrast-enhanced MR imaging parameters and histopathologic findings.
    van Dijke CF; Kirk BA; Peterfy CG; Genant HK; Brasch RC; Kapila S
    Radiology; 1997 Sep; 204(3):825-32. PubMed ID: 9280267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macromolecular intravenous contrast agent for MR lymphography: characterization and efficacy studies.
    Harika L; Weissleder R; Poss K; Papisov MI
    Radiology; 1996 Feb; 198(2):365-70. PubMed ID: 8596833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA.
    Vogl TJ; Kümmel S; Hammerstingl R; Schellenbeck M; Schumacher G; Balzer T; Schwarz W; Müller PK; Bechstein WO; Mack MG; Söllner O; Felix R
    Radiology; 1996 Jul; 200(1):59-67. PubMed ID: 8657946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo imaging of extraction fraction of low molecular weight MR contrast agents and perfusion rate in rodent tumors.
    Kovar DA; Lewis MZ; River JN; Lipton MJ; Karczmar GS
    Magn Reson Med; 1997 Aug; 38(2):259-68. PubMed ID: 9256106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A MRI spatial mapping technique for microvascular permeability and tissue blood volume based on macromolecular contrast agent distribution.
    Demsar F; Roberts TP; Schwickert HC; Shames DM; van Dijke CF; Mann JS; Saeed M; Brasch RC
    Magn Reson Med; 1997 Feb; 37(2):236-42. PubMed ID: 9001148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic metastases: liposomal Gd-DTPA-enhanced MR imaging.
    Unger EC; Winokur T; MacDougall P; Rosenblum J; Clair M; Gatenby R; Tilcock C
    Radiology; 1989 Apr; 171(1):81-5. PubMed ID: 2928550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver metastases: improved detection with dynamic gadolinium-enhanced MR imaging?
    Hamm B; Mahfouz AE; Taupitz M; Mitchell DG; Nelson R; Halpern E; Speidel A; Wolf KJ; Saini S
    Radiology; 1997 Mar; 202(3):677-82. PubMed ID: 9051015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decrease in tumor apparent permeability-surface area product to a MRI macromolecular contrast medium following angiogenesis inhibition with correlations to cytotoxic drug accumulation.
    Daldrup-Link HE; Okuhata Y; Wolfe A; Srivastav S; Øie S; Ferrara N; Cohen RL; Shames DM; Brasch RC
    Microcirculation; 2004; 11(5):387-96. PubMed ID: 15280064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peritoneal tumor: MR imaging with dilute oral barium and intravenous gadolinium-containing contrast agents compared with unenhanced MR imaging and CT.
    Low RN; Barone RM; Lacey C; Sigeti JS; Alzate GD; Sebrechts CP
    Radiology; 1997 Aug; 204(2):513-20. PubMed ID: 9240546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathological animal models in the experimental evaluation of tumour microvasculature with magnetic resonance imaging.
    Faccioli N; Marzola P; Boschi F; Sbarbati A; D'Onofrio M; Pozzi Mucelli R
    Radiol Med; 2007 Apr; 112(3):319-28. PubMed ID: 17440699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic contrast-enhanced MR imaging of VX2 carcinomas after X-irradiation in rabbits: comparison of gadopentetate dimeglumine and a macromolecular contrast agent.
    Kim YH; Choi BI; Cho WH; Lim S; Moon WK; Han JK; Weinmann HJ; Chang KH
    Invest Radiol; 2003 Sep; 38(9):539-49. PubMed ID: 12960523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spatial mapping of microvascular permeability and tissue blood volume using magnetic resonance imaging.
    Demsar F; Roberts TP; Schwickert HC; Shames DM; van Dijke CF; Mann JS; Saeed M; Brasch RC
    Acad Radiol; 1996 Aug; 3 Suppl 2():S344-6. PubMed ID: 8796599
    [No Abstract]   [Full Text] [Related]  

  • 19. Prostate cancer tumor grade differentiation with dynamic contrast-enhanced MR imaging in the rat: comparison of macromolecular and small-molecular contrast media--preliminary experience.
    Gossmann A; Okuhata Y; Shames DM; Helbich TH; Roberts TP; Wendland MF; Huber S; Brasch RC
    Radiology; 1999 Oct; 213(1):265-72. PubMed ID: 10540670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Definition of peritumoral vessels with contrast-enhanced magnetic resonance imaging: comparison of gadopentetate dimeglumine and a blood-pool macromolecular contrast medium.
    Brasch RC; Schwickert HC; Roberts TP; Shames DM; van Dijke CF; Mann JS; Demsar F
    Acad Radiol; 1996 Aug; 3 Suppl 2():S464-5. PubMed ID: 8796630
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.